Jabil Healthcare is the industry’s largest, most comprehensive healthcare solutions and capabilities provider — giving our customers access to an array of engineering, design, and manufacturing solutions across multiple sectors in the healthcare industry. In the face of challenging technology and value-based mandates, we are committed to customer-centric operational excellence driving positive patient outcomes. To learn more, please visit www.jabil.com

ZS is a management consulting and technology firm focused on transforming global healthcare and beyond. We leverage our leading- edge analytics, plus the power of data, science and products, to help our clients make more intelligent decisions, deliver innovative solutions and improve outcomes for all. Founded in 1983, ZS has more than 12,000 employees in 35 offices worldwide. To learn more, visit http://www.zs.com/

Canopy Biosciences, a Bruker company, empowers innovation by providing access to cutting-edge spatial biology and multi-omic tools so biomedical researchers can drive scientific discovery faster. Our proprietary technology ChipCytometry™ is a quantitative multiplex immunofluorescence imaging method for the spatial analysis of complex tissues and mapping of cell populations with single-cell resolution. Supported by Canopy Spatial Services™ with our CLIA-certified laboratory, we provide a unique collection of spatial and single-cell technologies that accelerate the understanding of cellular diversity and interaction. Learn more at canopybiosciences.com

NanoViricides, Inc. is a clinical stage company creating novel nanomaterials called “nanoviricides™” to cure viral infections. Oral NV-387 is in Phase 1a/1b for COVID and also has demonstrated broad-spectrum activity against multiple other viruses including RSV. Our safe nanomaterials can be receptor-targeted to deliver API cargo to specific cells. Our own multi-Kg-scale cGMP-compliant manufacturing facility has capabilities for making API and Drug Products (formulation, fill, finish, label, packaging). To learn more visit www.nanoviricides.com

GE HealthCare’s Pharmaceutical Diagnostics is a global leader in imaging agents. Its MI portfolio combines products across cardiology, neurology, and oncology, with a R&D pipeline, all aimed at enabling better-informed diagnosis and monitoring for improved clinical outcomes. For more information, visit https://www.gehealthcare.com/

Inimmune is a private clinical stage company dedicated to developing immuno-therapeutics. It is focused on advancing its Toll Like Receptor ligand portfolio as vaccine adjuvants, and immuno-therapeutics to be used alone or in combination to treat cancer, allergy, autoimmune disorders and infectious diseases. The company, through its chemistry, formulation and immunology expertise participates in a number of NIH-sponsored research collaborations with leading U.S. based universities developing vaccines to treat a variety of conditions including infectious diseases and opioid addiction. To learn more please visit: https://inimmune.com/

Mikron Automation is your worldwide partner for advanced assembly solutions. At Mikron we are committed to delivering the best assembly systems and all needed services throughout your product’s entire life cycle. With our extensive engineering know-how, complex process expertise, scalable platforms and lifelong support we are driving lasting success for your business. To learn more, visit www.mikron.com

At Median, we transform medical images into meaningful, actionable insights to help better diagnose, treat, and monitor patients. We harness the power of medical images by using the most advanced Artificial Intelligence technologies, to increase the accuracy of diagnosis and treatment of many cancers and other metabolic diseases at their earliest stages and provide insights into novel therapies for patients. Median’s Imaging CRO business provides leading oncology clinical trial imaging services, empowering our life sciences partners to accelerate the development and delivery of life-saving cancer treatments with unmatched operational excellence and reliability. And we don’t stop there. We are forging the way when it comes to innovative imaging technology, leveraging the latest in AI-powered imaging intelligence to develop actionable insights for sponsors worldwide. To learn more, visit https://mediantechnologies.com/

Scailyte is an ETH Zürich spin-off with a best-in-class artificial intelligence platform for the discovery of complex disease patterns from single-cell data. Our solution provides unprecedented insight into the disease and patients’ biology and enables the discovery of new clinically-relevant biomarker signatures by uncovering human’s hidden “single-cell” secrets. Scailyte’s proprietary best-in-class data analysis platform ScaiVision™ associates multimodal single-cell datasets (RNA-/TCR-/BCR-seq, proteomics, etc.) with clinical endpoints, such as disease diagnosis, progression, severity, treatment response, and toxicity response to identify ultra-sensitive biomarker signatures and cell functionality states. The performance and clinically-relevant applications of Scailyte’s platform ScaiVision have been demonstrated in well established CAR-T cell therapies and various clinical projects in Oncology and Immunology. For more information, visit: https://scailyte.com/

Scorpion Therapeutics is pioneering Precision Oncology 2.0 to deliver transformational therapies for larger populations of cancer patients. By combining our scientific expertise with advanced technologies, we exceed the performance of traditional discovery methods and develop molecules that are either best-in-class against validated oncogene targets or first-in-class for previously undruggable targets. For more information, please visit: www.scorpiontx.com

Crux was founded to address challenging technical briefs and deliver compelling solutions for the drug delivery and medical device sectors. Based in Bristol, United Kingdom, our technical team champion evidence-based problem solving, coupling world-class equipment, software and facilities with a scientific approach to maximise success. Be it discovering unmet user needs, developing novel products or deploying new technologies, our team are dedicated to solving our client’s biggest problems. To learn more, visit www.cruxproductdesign.com

Comera Life Sciences, Inc. is a preclinical stage biotech company developing a portfolio of proprietary antibodies that incorporate its proprietary formulation platform, SQore. The SQore platform converts intravenous (IV) biologics to subcutaneous (SQ) versions. We collaborate with partners interested in accessing our platform to convert biologics into out-patient delivered subcutaneous injections. Visit www.ComeraLifeSciences.com.